Generic drug
Insulin aspart, human price, strengths & recalls
Generic of NovoLog, Fiasp, Merilog
Pharmacies pay $134.41 for 15 mL of Insulin aspart, human 100 units/mL, 3 mL pen this week, and from $69.55 to $134.41 across its 3 priced strengths and forms. 3 manufacturers make it. It has 5 recalls on record, none ongoing. Its official label last changed on June 17, 2026.
Generic- Fair cash price
- $165.07
- Strengths
- 3
- Makers
- 3
- Updated
- Nov 11
Insulin aspart, human price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 units/mL, 3 mL cartridge | $8.57 | $128.56 / 15 mL |
| 100 units/mL injection | $6.95 | $69.55 / 10 mL |
| 100 units/mL, 3 mL pen | $8.96 | $134.41 / 15 mL |
Brand names of insulin aspart, human
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Medicare negotiated price
Medicare negotiated a maximum fair price of $119.00 for a 30-day supply of NovoLog / Fiasp, against a 2023 list price of $495.00. It has applied since January 1, 2026.
What this means for patients
- The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
- What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
- Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
- If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Insulin aspart, human
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART.INSULIN ASPART injection, for subcutaneous or intravenous useInitial U.S. Approval: 2000This product is NovoLog (insulin aspart).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- BLA020986 · Novo Nordisk Inc
- First approved
- June 7, 2000 (26 years ago)
- Latest approved change
- February 28, 2023
- Approved label
- PDF, Mar 1, 2023
- Generic makers
- None on the market
Insulin aspart, human questions
How much does insulin aspart, human cost without insurance?
Pharmacies pay about $134.41 for 15 mL of insulin aspart, human 100 units/mL, 3 mL pen ($8.96 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $165.07. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of insulin aspart, human?
Is insulin aspart, human in shortage?
No shortage is reported for insulin aspart, human right now. We check the national shortage list every day.
Has insulin aspart, human been recalled?
5 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the insulin aspart, human label last change?
The official label was last updated on June 17, 2026 (version 6). See what changed.
Does Medicare have a negotiated price for Insulin aspart, human?
Yes: $119.00 for a 30-day supply of NovoLog / Fiasp, from January 1, 2026. What you pay still depends on your plan.
Talk about insulin aspart, human
No comments yet. Questions, tips, what worked for you - start the conversation.